Connessioni Novartis AG

NOVN

CH0012005267

Prodotti farmaceutici

Mercato chiuso - Swiss Exchange Altri mercati azionari 17:30:57 05/12/2025			Variaz. 5gg	Var. 1 gen.
107,08 ^CHF	+0,19%		+2,49%	+20,72%

05/12	Novartis alza le ambizioni di crescita a medio termine mentre il target price viene aumentato
05/12	Dividendi attesi in rialzo per gran parte delle aziende svizzere	AW

46

Società nel listino

50

Aziende private

463

Insiders

Grafico di relazione delle società quotate collegate: Novartis AG

Relazioni attive

Relazioni passate

Società quotate collegate: Novartis AG

INCYTE CORPORATION

Pablo Cagnoni

Susanne Antonie Schaffert

STMICROELECTRONICS N.V.

Ana de Pro Gonzalo

METTLER-TOLEDO INTERNATIONAL, INC.

Ingrid Zhang

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Nancy Andrews

MONDELEZ INTERNATIONAL, INC.

Dirk van de Put

Brian McNamara

SONOMA PHARMACEUTICALS, INC.

Jay Birnbaum

Philippe Weigerstorfer

MILESTONE PHARMACEUTICALS INC.

Joseph Papa

Guy Rousseau

AURA BIOSCIENCES, INC.

SANTHERA PHARMACEUTICALS HOLDING AG

BURCKHARDT COMPRESSION HOLDING AG

Debra Stephanie Barker

CANDEL THERAPEUTICS, INC.

PLIANT THERAPEUTICS, INC.

FULGENT GENETICS, INC.

Michael Nohaile

JOHNSON CONTROLS INTERNATIONAL PLC

INTEGRAL AD SCIENCE HOLDING CORP.

Bridgette Heller

CUREVAC N.V.

Debra Stephanie Barker

TANGO THERAPEUTICS, INC.

Barbara Weber

Malte Peters

WHITEHAWK THERAPEUTICS, INC.

David Lennon

FRAZIER LIFESCIENCES ACQUISITION CORPORATION

Relazioni attive

Relazioni passate

Grafico delle relazioni per le aziende private collegate: Novartis AG

Relazioni attive

Relazioni passate

Aziende private collegate: Novartis AG

Novartis, Inc.

Pharmaceuticals: Major

William Brody

Hans Jörg Reinhardt

Novartis International AG

Pharmaceuticals: Major

Helsinn Healthcare SA

Pharmaceuticals: Major

Eric Cornut

Siddharth Kaul

Biotechnology Innovation Organization

Miscellaneous Commercial Services

Serica Technologies, Inc.

Pharmaceuticals: Major

F. Ball

David Pyott

STADA Arzneimittel AG

Pharmaceuticals: Generic

Eric Cornut

Miguel Fernandez

Novo Holdings A/S (Denmark)

Financial Conglomerates

Susanne Antonie Schaffert

Viviane Monges

Institute of Chartered Accountants in England & Wales

Miscellaneous Commercial Services

Jonathan Symonds

John McAdoo

The General Hospital Corp.

Hospital/Nursing Management

Mark Fishman

Mason W. Freeman

Atlas Venture Advisors, Inc.

Investment Managers

Jeffrey Hrkach

Vic Myer

University of St. Gallen

Other Consumer Services

Thomas Werlen

Ruth Metzler-Arnold

American Bar Association

Miscellaneous Commercial Services

Shannon Klinger

Diane E. Sugrue

Novartis Pharmaceuticals Corp.

Pharmaceuticals: Major

Hans Jörg Reinhardt

Thomas N. Kendris

Vasant Narasimhan

University of Basel

Other Consumer Services

Speedel Pharma AG

Pharmaceuticals: Major

Thomas Littke

Peter Herold

National Academy of Sciences

Miscellaneous Commercial Services

William J. Rutter

Charles Sawyers

Nancy Andrews

American Academy of Arts & Sciences

Miscellaneous Commercial Services

Ann Marie Fudge

William J. Rutter

Charles Sawyers

National Academy of Engineering

Miscellaneous Commercial Services

William Brody

William George

National Academy of Medicine (United States)

Miscellaneous Commercial Services

The District of Columbia Bar

Miscellaneous Commercial Services

Shannon Klinger

Theresa Maria Stevens

European Federation of Pharmaceutical Industries & Assns

Miscellaneous Commercial Services

Kim Stratton

Giovanni Caforio

Massachusetts Biotechnology Council

Miscellaneous Commercial Services

Abbie Celniker

Udit Batra

Novartis Institutes for Biomedical Research, Inc.

Miscellaneous Commercial Services

Hans Jörg Reinhardt

Harry Werner Kirsch

Third Rock Ventures LLC

Investment Managers

Abbie Celniker

Barbara Weber

Novartis Pharma AG

Pharmaceuticals: Major

Harvard Medical School

Other Consumer Services

Mason W. Freeman

Nancy Andrews

Waters Technologies Corp.

Medical Specialties

Udit Batra

Amol Chaubal

E. Merck KG

Pharmaceuticals: Major

Susanne Antonie Schaffert

André Wyss

IMD Scholarship Foundation

Karen Hübscher

Marie-France Tschudin

SIX Swiss Exchange AG

Investment Banks/Brokers

Thomas Werlen

Andreas von Planta

Novartis Pharma KK

Pharmaceuticals: Major

Novartis Pharma BV

Swiss Bar Association

Felix R. Ehrat

Laurent Sigismondi

Zurich Bar Association

Felix R. Ehrat

Daniel Hochstrasser

The Consumer Goods Forum

Miscellaneous Commercial Services

Dirk van de Put

Brian McNamara

Association of the European Self-Medication Industry

Affidea BV

Galderma Holding SA

Vasomune Therapeutics, Inc.

Meenu Chhabra Karson

Meenu Karson

Fore Biotherapeutics, Inc.

Novartis Foundation

Tango Therapeutics Sub, Inc.

Barbara Weber

Malte Peters

CIBA Vision GmbH (Germany)

Felix R. Ehrat

Susanne Antonie Schaffert

ImmunOs Therapeutics AG

Daniel Vasella

Reinhard Ambros

Ring Therapeutics, Inc.

David Epstein

Juan Andres

Medartis AG

Marco Gadola

Anthony Durieux-Menage

Valo Health LLC

David Epstein

Shreeram Aradhye

Abata Therapeutics, Inc.

Teres Bio, Inc.

Anteris Bio, Inc.

Relazioni attive

Relazioni passate

Statistiche di connessione

Attive

Inattive

Società nel listino

Aziende private

Attività di società collegate

Pharmaceuticals: Major	15
Miscellaneous Commercial Services	13
Medical Specialties	7
Other Consumer Services	3
Investment Managers	2
Food: Specialty/Candy	2
Industrial Machinery	2
Biotechnology	1
Other Transportation	1
Real Estate Development	1

Paese delle società collegate

Stati Uniti	45
Svizzera	28
Paesi Bassi	5
Germania	4
Belgio	3
Danimarca	2
Regno Unito	2
Canada	2
Francia	1
Giappone	1

Novartis AG è uno dei leader mondiali nella progettazione, produzione e commercializzazione di prodotti farmaceutici. Le vendite nette sono suddivise per area terapeutica come segue: - oncologia (29,3%); - immunologia (18,5%); - malattie cardiovascolari, renali e metaboliche (17%); - neuroscienze (9,4%). Le vendite nette rimanenti (25,8%) derivano dalla produzione a contratto di prodotti farmaceutici. Alla fine del 2024, Novartis AG aveva oltre 30 siti di produzione in tutto il mondo. Le vendite nette sono distribuite geograficamente come segue: Europa (30,9%), Stati Uniti (42%), Asia/Africa/Australasia (20%), Canada e America Latina (7,1%).

Dipendenti

75.883

Settore

Prodotti farmaceutici

Calendario

23:15 - American Society of Hematology Meeting - Abstract No - #724

Altre informazioni sulla società

Connessioni Novartis AG

Azioni

NOVN

CH0012005267

Prodotti farmaceutici

46

50

463

Grafico di relazione delle società quotate collegate: Novartis AG

Società quotate collegate: Novartis AG

Grafico delle relazioni per le aziende private collegate: Novartis AG

Aziende private collegate: Novartis AG

Statistiche di connessione

Attività di società collegate

Paese delle società collegate

Profilo Società